Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Polyp Forcep Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Polyp Forcep Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-08-05
Pages: 165 Pages
Report ld: 4884021
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Polyp Forcep market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A polyp forceps is a medical device mainly used to remove polyps in the intestine, uterus or other parts.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Polyp Forcep leading manufacturers including Medline Industries, Inc., DTR Medical, CooperSurgical, Integra LifeSciences (Integra), BD, Surtex Instruments, Meister Surgical, BR Surgical, Vernacare, Bolton Surgical, etc., dominate supply; the top five capture approximately % of global revenue, with Medline Industries, Inc. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Polyp Forcep market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Medline Industries, Inc.
- DTR Medical
- CooperSurgical
- Integra LifeSciences (Integra)
- BD
- Surtex Instruments
- Meister Surgical
- BR Surgical
- Vernacare
- Bolton Surgical
- Surgical Holdings
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Intestinal Polyp Forceps
- Nasal Polyp Forceps
- Uterine Polyp Forceps
- Others
Segment by Application
- Hospital
- Clinic
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Polyp Forcep study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Polyp Forcep: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Polyp Forcep Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Intestinal Polyp Forceps
1.2.3 Nasal Polyp Forceps
1.2.4 Uterine Polyp Forceps
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Polyp Forcep Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Polyp Forcep Revenue Estimates and Forecasts 2020-2031
2.2 Global Polyp Forcep Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Polyp Forcep Sales Estimates and Forecasts 2020-2031
2.4 Global Polyp Forcep Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Polyp Forcep Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Polyp Forcep Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Intestinal Polyp Forceps Market Size by Manufacturers
3.5.2 Nasal Polyp Forceps Market Size by Manufacturers
3.5.3 Uterine Polyp Forceps Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Polyp Forcep Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Polyp Forcep Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Polyp Forcep Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Polyp Forcep Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Polyp Forcep Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Polyp Forcep Sales and Revenue by Type (2020-2031)
6.4 North America Polyp Forcep Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Polyp Forcep Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Polyp Forcep Sales and Revenue by Type (2020-2031)
7.4 Europe Polyp Forcep Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Polyp Forcep Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Polyp Forcep Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Polyp Forcep Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Polyp Forcep Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Polyp Forcep Sales and Revenue by Type (2020-2031)
9.4 Central and South America Polyp Forcep Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Polyp Forcep Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Polyp Forcep Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Polyp Forcep Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Polyp Forcep Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medline Industries, Inc.
11.1.1 Medline Industries, Inc. Corporation Information
11.1.2 Medline Industries, Inc. Business Overview
11.1.3 Medline Industries, Inc. Polyp Forcep Product Models, Descriptions and Specifications
11.1.4 Medline Industries, Inc. Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medline Industries, Inc. Polyp Forcep Sales by Product in 2024
11.1.6 Medline Industries, Inc. Polyp Forcep Sales by Application in 2024
11.1.7 Medline Industries, Inc. Polyp Forcep Sales by Geographic Area in 2024
11.1.8 Medline Industries, Inc. Polyp Forcep SWOT Analysis
11.1.9 Medline Industries, Inc. Recent Developments
11.2 DTR Medical
11.2.1 DTR Medical Corporation Information
11.2.2 DTR Medical Business Overview
11.2.3 DTR Medical Polyp Forcep Product Models, Descriptions and Specifications
11.2.4 DTR Medical Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 DTR Medical Polyp Forcep Sales by Product in 2024
11.2.6 DTR Medical Polyp Forcep Sales by Application in 2024
11.2.7 DTR Medical Polyp Forcep Sales by Geographic Area in 2024
11.2.8 DTR Medical Polyp Forcep SWOT Analysis
11.2.9 DTR Medical Recent Developments
11.3 CooperSurgical
11.3.1 CooperSurgical Corporation Information
11.3.2 CooperSurgical Business Overview
11.3.3 CooperSurgical Polyp Forcep Product Models, Descriptions and Specifications
11.3.4 CooperSurgical Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 CooperSurgical Polyp Forcep Sales by Product in 2024
11.3.6 CooperSurgical Polyp Forcep Sales by Application in 2024
11.3.7 CooperSurgical Polyp Forcep Sales by Geographic Area in 2024
11.3.8 CooperSurgical Polyp Forcep SWOT Analysis
11.3.9 CooperSurgical Recent Developments
11.4 Integra LifeSciences (Integra)
11.4.1 Integra LifeSciences (Integra) Corporation Information
11.4.2 Integra LifeSciences (Integra) Business Overview
11.4.3 Integra LifeSciences (Integra) Polyp Forcep Product Models, Descriptions and Specifications
11.4.4 Integra LifeSciences (Integra) Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Integra LifeSciences (Integra) Polyp Forcep Sales by Product in 2024
11.4.6 Integra LifeSciences (Integra) Polyp Forcep Sales by Application in 2024
11.4.7 Integra LifeSciences (Integra) Polyp Forcep Sales by Geographic Area in 2024
11.4.8 Integra LifeSciences (Integra) Polyp Forcep SWOT Analysis
11.4.9 Integra LifeSciences (Integra) Recent Developments
11.5 BD
11.5.1 BD Corporation Information
11.5.2 BD Business Overview
11.5.3 BD Polyp Forcep Product Models, Descriptions and Specifications
11.5.4 BD Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 BD Polyp Forcep Sales by Product in 2024
11.5.6 BD Polyp Forcep Sales by Application in 2024
11.5.7 BD Polyp Forcep Sales by Geographic Area in 2024
11.5.8 BD Polyp Forcep SWOT Analysis
11.5.9 BD Recent Developments
11.6 Surtex Instruments
11.6.1 Surtex Instruments Corporation Information
11.6.2 Surtex Instruments Business Overview
11.6.3 Surtex Instruments Polyp Forcep Product Models, Descriptions and Specifications
11.6.4 Surtex Instruments Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Surtex Instruments Recent Developments
11.7 Meister Surgical
11.7.1 Meister Surgical Corporation Information
11.7.2 Meister Surgical Business Overview
11.7.3 Meister Surgical Polyp Forcep Product Models, Descriptions and Specifications
11.7.4 Meister Surgical Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Meister Surgical Recent Developments
11.8 BR Surgical
11.8.1 BR Surgical Corporation Information
11.8.2 BR Surgical Business Overview
11.8.3 BR Surgical Polyp Forcep Product Models, Descriptions and Specifications
11.8.4 BR Surgical Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 BR Surgical Recent Developments
11.9 Vernacare
11.9.1 Vernacare Corporation Information
11.9.2 Vernacare Business Overview
11.9.3 Vernacare Polyp Forcep Product Models, Descriptions and Specifications
11.9.4 Vernacare Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Vernacare Recent Developments
11.10 Bolton Surgical
11.10.1 Bolton Surgical Corporation Information
11.10.2 Bolton Surgical Business Overview
11.10.3 Bolton Surgical Polyp Forcep Product Models, Descriptions and Specifications
11.10.4 Bolton Surgical Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Bolton Surgical Recent Developments
11.11 Surgical Holdings
11.11.1 Surgical Holdings Corporation Information
11.11.2 Surgical Holdings Business Overview
11.11.3 Surgical Holdings Polyp Forcep Product Models, Descriptions and Specifications
11.11.4 Surgical Holdings Polyp Forcep Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Surgical Holdings Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Polyp Forcep Industry Chain
12.2 Polyp Forcep Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Polyp Forcep Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Polyp Forcep Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Polyp Forcep Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Polyp Forcep Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Polyp Forcep Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Polyp Forcep Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Polyp Forcep Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Polyp Forcep Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Polyp Forcep Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Polyp Forcep Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Polyp Forcep Sales by Region (2020-2025) & (K Units)
Table 8. Global Polyp Forcep Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Polyp Forcep Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Polyp Forcep Sales Share by Manufacturers (2020-2025)
Table 12. Global Polyp Forcep Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Polyp Forcep Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Polyp Forcep by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polyp Forcep as of 2024)
Table 16. Global Polyp Forcep Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Polyp Forcep Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Polyp Forcep Manufacturing Base and Headquarters
Table 19. Global Polyp Forcep Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Polyp Forcep Sales by Type (2020-2025) & (K Units)
Table 23. Global Polyp Forcep Sales by Type (2026-2031) & (K Units)
Table 24. Global Polyp Forcep Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Polyp Forcep Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Polyp Forcep ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Polyp Forcep Sales by Application (2020-2025) & (K Units)
Table 29. Global Polyp Forcep Sales by Application (2026-2031) & (K Units)
Table 30. Polyp Forcep High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Polyp Forcep Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Polyp Forcep Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Polyp Forcep ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Polyp Forcep Growth Accelerators and Market Barriers
Table 37. North America Polyp Forcep Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Polyp Forcep Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Polyp Forcep Growth Accelerators and Market Barriers
Table 40. Europe Polyp Forcep Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Polyp Forcep Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Polyp Forcep Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Polyp Forcep Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Polyp Forcep Growth Accelerators and Market Barriers
Table 45. Southeast Asia Polyp Forcep Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Polyp Forcep Investment Opportunities and Key Challenges
Table 47. Central and South America Polyp Forcep Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Polyp Forcep Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Polyp Forcep Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medline Industries, Inc. Corporation Information
Table 51. Medline Industries, Inc. Description and Major Businesses
Table 52. Medline Industries, Inc. Product Models, Descriptions and Specifications
Table 53. Medline Industries, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Medline Industries, Inc. Sales Value Proportion by Product in 2024
Table 55. Medline Industries, Inc. Sales Value Proportion by Application in 2024
Table 56. Medline Industries, Inc. Sales Value Proportion by Geographic Area in 2024
Table 57. Medline Industries, Inc. Polyp Forcep SWOT Analysis
Table 58. Medline Industries, Inc. Recent Developments
Table 59. DTR Medical Corporation Information
Table 60. DTR Medical Description and Major Businesses
Table 61. DTR Medical Product Models, Descriptions and Specifications
Table 62. DTR Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. DTR Medical Sales Value Proportion by Product in 2024
Table 64. DTR Medical Sales Value Proportion by Application in 2024
Table 65. DTR Medical Sales Value Proportion by Geographic Area in 2024
Table 66. DTR Medical Polyp Forcep SWOT Analysis
Table 67. DTR Medical Recent Developments
Table 68. CooperSurgical Corporation Information
Table 69. CooperSurgical Description and Major Businesses
Table 70. CooperSurgical Product Models, Descriptions and Specifications
Table 71. CooperSurgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. CooperSurgical Sales Value Proportion by Product in 2024
Table 73. CooperSurgical Sales Value Proportion by Application in 2024
Table 74. CooperSurgical Sales Value Proportion by Geographic Area in 2024
Table 75. CooperSurgical Polyp Forcep SWOT Analysis
Table 76. CooperSurgical Recent Developments
Table 77. Integra LifeSciences (Integra) Corporation Information
Table 78. Integra LifeSciences (Integra) Description and Major Businesses
Table 79. Integra LifeSciences (Integra) Product Models, Descriptions and Specifications
Table 80. Integra LifeSciences (Integra) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Integra LifeSciences (Integra) Sales Value Proportion by Product in 2024
Table 82. Integra LifeSciences (Integra) Sales Value Proportion by Application in 2024
Table 83. Integra LifeSciences (Integra) Sales Value Proportion by Geographic Area in 2024
Table 84. Integra LifeSciences (Integra) Polyp Forcep SWOT Analysis
Table 85. Integra LifeSciences (Integra) Recent Developments
Table 86. BD Corporation Information
Table 87. BD Description and Major Businesses
Table 88. BD Product Models, Descriptions and Specifications
Table 89. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. BD Sales Value Proportion by Product in 2024
Table 91. BD Sales Value Proportion by Application in 2024
Table 92. BD Sales Value Proportion by Geographic Area in 2024
Table 93. BD Polyp Forcep SWOT Analysis
Table 94. BD Recent Developments
Table 95. Surtex Instruments Corporation Information
Table 96. Surtex Instruments Description and Major Businesses
Table 97. Surtex Instruments Product Models, Descriptions and Specifications
Table 98. Surtex Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Surtex Instruments Recent Developments
Table 100. Meister Surgical Corporation Information
Table 101. Meister Surgical Description and Major Businesses
Table 102. Meister Surgical Product Models, Descriptions and Specifications
Table 103. Meister Surgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Meister Surgical Recent Developments
Table 105. BR Surgical Corporation Information
Table 106. BR Surgical Description and Major Businesses
Table 107. BR Surgical Product Models, Descriptions and Specifications
Table 108. BR Surgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. BR Surgical Recent Developments
Table 110. Vernacare Corporation Information
Table 111. Vernacare Description and Major Businesses
Table 112. Vernacare Product Models, Descriptions and Specifications
Table 113. Vernacare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Vernacare Recent Developments
Table 115. Bolton Surgical Corporation Information
Table 116. Bolton Surgical Description and Major Businesses
Table 117. Bolton Surgical Product Models, Descriptions and Specifications
Table 118. Bolton Surgical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Bolton Surgical Recent Developments
Table 120. Surgical Holdings Corporation Information
Table 121. Surgical Holdings Description and Major Businesses
Table 122. Surgical Holdings Product Models, Descriptions and Specifications
Table 123. Surgical Holdings Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Surgical Holdings Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Polyp Forcep Product Picture
Figure 2. Global Polyp Forcep Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Intestinal Polyp Forceps Product Picture
Figure 4. Nasal Polyp Forceps Product Picture
Figure 5. Uterine Polyp Forceps Product Picture
Figure 6. Others Product Picture
Figure 7. Global Polyp Forcep Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Polyp Forcep Report Years Considered
Figure 12. Global Polyp Forcep Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 14. Global Polyp Forcep Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Polyp Forcep Revenue Market Share by Region (2020-2031)
Figure 16. Global Polyp Forcep Sales (2020-2031) & (K Units)
Figure 17. Global Polyp Forcep Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Polyp Forcep Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Polyp Forcep Sales Volume Market Share in 2024
Figure 20. Global Polyp Forcep Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Intestinal Polyp Forceps Revenue Market Share by Manufacturer in 2024
Figure 23. Nasal Polyp Forceps Revenue Market Share by Manufacturer in 2024
Figure 24. Uterine Polyp Forceps Revenue Market Share by Manufacturer in 2024
Figure 25. Others Revenue Market Share by Manufacturer in 2024
Figure 26. Global Polyp Forcep Sales Market Share by Type (2020-2031)
Figure 27. Global Polyp Forcep Revenue Market Share by Type (2020-2031)
Figure 28. Global Polyp Forcep Sales Market Share by Application (2020-2031)
Figure 29. Global Polyp Forcep Revenue Market Share by Application (2020-2031)
Figure 30. North America Polyp Forcep Sales YoY (2020-2031) & (K Units)
Figure 31. North America Polyp Forcep Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Polyp Forcep Sales Revenue (US$ Million) in 2024
Figure 33. North America Polyp Forcep Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Polyp Forcep Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Polyp Forcep Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Polyp Forcep Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Polyp Forcep Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Polyp Forcep Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Polyp Forcep Sales Revenue (US$ Million) in 2024
Figure 43. Europe Polyp Forcep Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Polyp Forcep Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Polyp Forcep Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Polyp Forcep Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 48. France Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Polyp Forcep Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Polyp Forcep Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Polyp Forcep Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Polyp Forcep Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Polyp Forcep Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Polyp Forcep Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Polyp Forcep Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 63. India Polyp Forcep Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Polyp Forcep Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Polyp Forcep Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Polyp Forcep Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Polyp Forcep Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Polyp Forcep Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Polyp Forcep Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Polyp Forcep Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Polyp Forcep Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Polyp Forcep Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Polyp Forcep Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Polyp Forcep Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Polyp Forcep Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Polyp Forcep Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Polyp Forcep Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Polyp Forcep Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Polyp Forcep Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Polyp Forcep Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Polyp Forcep Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Polyp Forcep Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Polyp Forcep Revenue (2020-2025) & (US$ Million)
Figure 84. Polyp Forcep Industry Chain Mapping
Figure 85. Regional Polyp Forcep Manufacturing Base Distribution (%)
Figure 86. Global Polyp Forcep Production Market Share by Region (2020-2031)
Figure 87. Polyp Forcep Production Process
Figure 88. Regional Polyp Forcep Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Polyp Forcep market?
The top companies in the global Polyp Forcep market are Medline Industries, Inc.、DTR Medical、CooperSurgical.
Related Reports
Global Polyp Forcep Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Polyp Forcep market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 167
USD 4900.00
(Single User License)
Global Polyp Forcep Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Polyp Forcep market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 98
USD 4250.00
(Single User License)
Polyp Forcep- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polyp Forcep was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 115
USD 3950.00
(Single User License)
Global Polyp Forcep Market Research Report 2026
The global Polyp Forcep market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 124
USD 2900.00
(Single User License)
Global Polyp Forcep Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polyp Forcep market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 93
USD 4250.00
(Single User License)
Polyp Forcep - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Polyp Forcep was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 120
USD 3950.00
(Single User License)
Global Polyp Forcep Market Research Report 2025
The global market for Polyp Forcep was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 93
USD 2900.00
(Single User License)
Global and United States Polyp Forcep Market Report & Forecast 2024-2030
A polyp forceps is a medical device mainly used to remove polyps in the intestine, uterus or other parts.
Published Date: 2024-06-21
Pages: 121
USD 4350.00
(Single User License)
Global Polyp Forcep Market Insights, Forecast to 2030
A polyp forceps is a medical device mainly used to remove polyps in the intestine, uterus or other parts.
Published Date: 2024-06-21
Pages: 153
USD 4900.00
(Single User License)
Polyp Forcep- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A polyp forceps is a medical device mainly used to remove polyps in the intestine, uterus or other parts.
Published Date: 2024-06-21
Pages: 124
USD 3950.00
(Single User License)
Global Polyp Forcep Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Polyp Forcep market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 167
USD 4900.00 (Single User License)Global Polyp Forcep Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Polyp Forcep market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 98
USD 4250.00 (Single User License)Polyp Forcep- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polyp Forcep was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 115
USD 3950.00 (Single User License)Global Polyp Forcep Market Research Report 2026
The global Polyp Forcep market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 124
USD 2900.00 (Single User License)Global Polyp Forcep Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polyp Forcep market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 93
USD 4250.00 (Single User License)Polyp Forcep - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Polyp Forcep was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 120
USD 3950.00 (Single User License)Global Polyp Forcep Market Research Report 2025
The global market for Polyp Forcep was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 93
USD 2900.00 (Single User License)Global and United States Polyp Forcep Market Report & Forecast 2024-2030
A polyp forceps is a medical device mainly used to remove polyps in the intestine, uterus or other parts.
Published: 2024-06-21
Pages: 121
USD 4350.00 (Single User License)Global Polyp Forcep Market Insights, Forecast to 2030
A polyp forceps is a medical device mainly used to remove polyps in the intestine, uterus or other parts.
Published: 2024-06-21
Pages: 153
USD 4900.00 (Single User License)Polyp Forcep- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A polyp forceps is a medical device mainly used to remove polyps in the intestine, uterus or other parts.
Published: 2024-06-21
Pages: 124
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now